Tripchlorolide May Improve Spatial Cognition Dysfunction and Synaptic Plasticity after Chronic Cerebral Hypoperfusion

Chronic cerebral hypoperfusion (CCH) is a common pathophysiological mechanism that underlies cognitive decline and degenerative processes in dementia and other neurodegenerative diseases. Low cerebral blood flow (CBF) during CCH leads to disturbances in the homeostasis of hemodynamics and energy met...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhao-Hui Yao, Xiao-li Yao, Shao-feng Zhang, Ji-chang Hu, Yong Zhang
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2019/2158285
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560935393296384
author Zhao-Hui Yao
Xiao-li Yao
Shao-feng Zhang
Ji-chang Hu
Yong Zhang
author_facet Zhao-Hui Yao
Xiao-li Yao
Shao-feng Zhang
Ji-chang Hu
Yong Zhang
author_sort Zhao-Hui Yao
collection DOAJ
description Chronic cerebral hypoperfusion (CCH) is a common pathophysiological mechanism that underlies cognitive decline and degenerative processes in dementia and other neurodegenerative diseases. Low cerebral blood flow (CBF) during CCH leads to disturbances in the homeostasis of hemodynamics and energy metabolism, which in turn results in oxidative stress, astroglia overactivation, and synaptic protein downregulation. These events contribute to synaptic plasticity and cognitive dysfunction after CCH. Tripchlorolide (TRC) is an herbal compound with potent neuroprotective effects. The potential of TRC to improve CCH-induced cognitive impairment has not yet been determined. In the current study, we employed behavioral techniques, electrophysiology, Western blotting, immunofluorescence, and Golgi staining to investigate the effect of TRC on spatial learning and memory impairment and on synaptic plasticity changes in rats after CCH. Our findings showed that TRC could rescue CCH-induced spatial learning and memory dysfunction and improve long-term potentiation (LTP) disorders. We also found that TRC could prevent CCH-induced reductions in N-methyl-D-aspartic acid receptor 2B, synapsin I, and postsynaptic density protein 95 levels. Moreover, TRC upregulated cAMP-response element binding protein, which is an important transcription factor for synaptic proteins. TRC also prevented the reduction in dendritic spine density that is caused by CCH. However, sham rats treated with TRC did not show any improvement in cognition. Because CCH causes disturbances in brain energy homeostasis, TRC therapy may resolve this instability by correcting a variety of cognitive-related signaling pathways. However, for the normal brain, TRC treatment led to neither disturbance nor improvement in neural plasticity. Additionally, this treatment neither impaired nor further improved cognition. In conclusion, we found that TRC can improve spatial learning and memory, enhance synaptic plasticity, upregulate the expression of some synaptic proteins, and increase the density of dendritic spines. Our findings suggest that TRC may be beneficial in the treatment of cognitive impairment induced by CCH.
format Article
id doaj-art-30ec836e050b415d9a8f833d3290ccf8
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-30ec836e050b415d9a8f833d3290ccf82025-02-03T01:26:19ZengWileyNeural Plasticity2090-59041687-54432019-01-01201910.1155/2019/21582852158285Tripchlorolide May Improve Spatial Cognition Dysfunction and Synaptic Plasticity after Chronic Cerebral HypoperfusionZhao-Hui Yao0Xiao-li Yao1Shao-feng Zhang2Ji-chang Hu3Yong Zhang4Department of Geriatrics, Renmin Hospital of Wuhan University, #238 Jiefang Road, Wuhan, ChinaDepartment of Neurology, Central Hospital of Zhengzhou, #195 Tongbo Road, Zhengzhou, ChinaDepartment of Neurology, Renmin Hospital of Wuhan University, #238 Jiefang Road, Wuhan, ChinaDepartment of Pathology, Renmin Hospital of Wuhan University, #238 Jiefang Road, Wuhan, ChinaDepartment of Neurology, Renmin Hospital of Wuhan University, #238 Jiefang Road, Wuhan, ChinaChronic cerebral hypoperfusion (CCH) is a common pathophysiological mechanism that underlies cognitive decline and degenerative processes in dementia and other neurodegenerative diseases. Low cerebral blood flow (CBF) during CCH leads to disturbances in the homeostasis of hemodynamics and energy metabolism, which in turn results in oxidative stress, astroglia overactivation, and synaptic protein downregulation. These events contribute to synaptic plasticity and cognitive dysfunction after CCH. Tripchlorolide (TRC) is an herbal compound with potent neuroprotective effects. The potential of TRC to improve CCH-induced cognitive impairment has not yet been determined. In the current study, we employed behavioral techniques, electrophysiology, Western blotting, immunofluorescence, and Golgi staining to investigate the effect of TRC on spatial learning and memory impairment and on synaptic plasticity changes in rats after CCH. Our findings showed that TRC could rescue CCH-induced spatial learning and memory dysfunction and improve long-term potentiation (LTP) disorders. We also found that TRC could prevent CCH-induced reductions in N-methyl-D-aspartic acid receptor 2B, synapsin I, and postsynaptic density protein 95 levels. Moreover, TRC upregulated cAMP-response element binding protein, which is an important transcription factor for synaptic proteins. TRC also prevented the reduction in dendritic spine density that is caused by CCH. However, sham rats treated with TRC did not show any improvement in cognition. Because CCH causes disturbances in brain energy homeostasis, TRC therapy may resolve this instability by correcting a variety of cognitive-related signaling pathways. However, for the normal brain, TRC treatment led to neither disturbance nor improvement in neural plasticity. Additionally, this treatment neither impaired nor further improved cognition. In conclusion, we found that TRC can improve spatial learning and memory, enhance synaptic plasticity, upregulate the expression of some synaptic proteins, and increase the density of dendritic spines. Our findings suggest that TRC may be beneficial in the treatment of cognitive impairment induced by CCH.http://dx.doi.org/10.1155/2019/2158285
spellingShingle Zhao-Hui Yao
Xiao-li Yao
Shao-feng Zhang
Ji-chang Hu
Yong Zhang
Tripchlorolide May Improve Spatial Cognition Dysfunction and Synaptic Plasticity after Chronic Cerebral Hypoperfusion
Neural Plasticity
title Tripchlorolide May Improve Spatial Cognition Dysfunction and Synaptic Plasticity after Chronic Cerebral Hypoperfusion
title_full Tripchlorolide May Improve Spatial Cognition Dysfunction and Synaptic Plasticity after Chronic Cerebral Hypoperfusion
title_fullStr Tripchlorolide May Improve Spatial Cognition Dysfunction and Synaptic Plasticity after Chronic Cerebral Hypoperfusion
title_full_unstemmed Tripchlorolide May Improve Spatial Cognition Dysfunction and Synaptic Plasticity after Chronic Cerebral Hypoperfusion
title_short Tripchlorolide May Improve Spatial Cognition Dysfunction and Synaptic Plasticity after Chronic Cerebral Hypoperfusion
title_sort tripchlorolide may improve spatial cognition dysfunction and synaptic plasticity after chronic cerebral hypoperfusion
url http://dx.doi.org/10.1155/2019/2158285
work_keys_str_mv AT zhaohuiyao tripchlorolidemayimprovespatialcognitiondysfunctionandsynapticplasticityafterchroniccerebralhypoperfusion
AT xiaoliyao tripchlorolidemayimprovespatialcognitiondysfunctionandsynapticplasticityafterchroniccerebralhypoperfusion
AT shaofengzhang tripchlorolidemayimprovespatialcognitiondysfunctionandsynapticplasticityafterchroniccerebralhypoperfusion
AT jichanghu tripchlorolidemayimprovespatialcognitiondysfunctionandsynapticplasticityafterchroniccerebralhypoperfusion
AT yongzhang tripchlorolidemayimprovespatialcognitiondysfunctionandsynapticplasticityafterchroniccerebralhypoperfusion